Request Demo
Last update 13 Sep 2025
Sulbactam sodium/Amoxicillin Sodium
Last update 13 Sep 2025
Overview
Basic Info
Drug Type Small molecule drug |
Synonyms 威奇达 |
Target |
Action inhibitors |
Mechanism β-lactamase inhibitors(Beta Lactamase inhibitors), Cell wall inhibitors |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhaseApproved |
First Approval Date China (01 Jan 2001), |
Regulation- |
Login to view timeline
Structure/Sequence
Molecular FormulaC16H19N3NaO5S |
InChIKeyMAOIJBVJXINZLX-YWUHCJSESA-N |
CAS Registry34642-77-8 |
View All Structures (2)
R&D Status
Approved
10 top approved records. to view more data
Login
| Indication | Country/Location | Organization | Date |
|---|---|---|---|
| Bacterial Infections | China | 01 Jan 2001 |
Developing
10 top R&D records. to view more data
Login
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Abdominal sepsis | Phase 2 | China | - | 17 Oct 2013 |
| Abscess of oral tissue | Phase 2 | China | - | 17 Oct 2013 |
| Cellulitis | Phase 2 | China | - | 17 Oct 2013 |
| Cystitis | Phase 2 | China | - | 17 Oct 2013 |
| Endocarditis | Phase 2 | China | - | 17 Oct 2013 |
| Gonorrhea | Phase 2 | China | - | 17 Oct 2013 |
| Gynecological infection | Phase 2 | China | - | 17 Oct 2013 |
| Intrauterine infection | Phase 2 | China | - | 17 Oct 2013 |
| Laryngitis | Phase 2 | China | - | 17 Oct 2013 |
| Osteomyelitis | Phase 2 | China | - | 17 Oct 2013 |
Login to view more data
Clinical Result
Clinical Result
Indication
Phase
Evaluation
View All Results
Login to view more data
Translational Medicine
Boost your research with our translational medicine data.
login
or
Deal
Boost your decision using our deal data.
login
or
Core Patent
Boost your research with our Core Patent data.
login
or
Clinical Trial
Identify the latest clinical trials across global registries.
login
or
Approval
Accelerate your research with the latest regulatory approval information.
login
or
Regulation
Understand key drug designations in just a few clicks with Synapse.
login
or
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free